Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host.

Zelini P, Lilleri D, Comolli G, Rognoni V, Chiesa A, Fornara C, Locatelli F, Meloni F, Gerna G.

Clin Immunol. 2010 Aug;136(2):269-81. doi: 10.1016/j.clim.2010.04.008. Epub 2010 May 20.

PMID:
20493777
2.

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.

Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G.

Clin Immunol. 2009 Jun;131(3):395-403. doi: 10.1016/j.clim.2009.02.002. Epub 2009 Mar 5.

PMID:
19268633
3.
4.

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.

Haematologica. 2008 Feb;93(2):248-56. doi: 10.3324/haematol.11912.

5.

Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.

Schermann CM, Fischer G, Witt V, Kurz M, Potschger U, Fritsch G.

Cytotherapy. 2008;10(8):834-41. doi: 10.1080/14653240802474315.

PMID:
19016371
6.

Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation.

Gerna G, Lilleri D, Fornara C, Comolli G, Lozza L, Campana C, Pellegrini C, Meloni F, Rampino T.

Am J Transplant. 2006 Oct;6(10):2356-64. Epub 2006 Aug 1.

8.

Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.

Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, Lilleri D.

New Microbiol. 2016 Oct;39(4):247-258. Epub 2016 Sep 13.

9.
10.

Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.

Gabanti E, Bruno F, Fornara C, Bernuzzi S, Lilleri D, Gerna G.

J Clin Immunol. 2014 Nov;34(8):999-1008. doi: 10.1007/s10875-014-0093-5. Epub 2014 Sep 18.

PMID:
25231588
11.

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.

Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M.

Blood. 2003 Oct 15;102(8):3060-7. Epub 2003 Jul 3.

12.
13.
14.

Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, Autran B, Dhedin N.

J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08. Epub 2008 Aug 6.

15.

Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.

Lilleri D, Gerna G, Fornara C, Chiesa A, Comolli G, Zecca M, Locatelli F.

J Infect Dis. 2009 Mar 15;199(6):829-36. doi: 10.1086/597123.

PMID:
19239337
16.

Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.

Hebart H, Daginik S, Stevanovic S, Grigoleit U, Dobler A, Baur M, Rauser G, Sinzger C, Jahn G, Loeffler J, Kanz L, Rammensee HG, Einsele H.

Blood. 2002 May 15;99(10):3830-7.

17.

Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.

Lilleri D, Fornara C, Revello MG, Gerna G.

J Infect Dis. 2008 Aug 15;198(4):536-43. doi: 10.1086/590118.

PMID:
18590456
18.

Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.

Gabanti E, Bruno F, Lilleri D, Fornara C, Zelini P, Cane I, Migotto C, Sarchi E, Furione M, Gerna G.

PLoS One. 2014 Aug 28;9(8):e106044. doi: 10.1371/journal.pone.0106044. eCollection 2014.

19.

Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.

Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR.

Transpl Infect Dis. 2009 Dec;11(6):519-28. doi: 10.1111/j.1399-3062.2009.00446.x. Epub 2009 Sep 9.

PMID:
19744286
20.

Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.

Gibson L, Piccinini G, Lilleri D, Revello MG, Wang Z, Markel S, Diamond DJ, Luzuriaga K.

J Immunol. 2004 Feb 15;172(4):2256-64.

Supplemental Content

Support Center